DOLORES M. PIRNIK
Bristol-Myers Squibb (Germany)(DE)Instytut Farmaceutyczny(PL)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, HIV/AIDS drug development and treatment, Carbohydrate Chemistry and Synthesis, Bacteriophages and microbial interactions, Fungal Biology and Applications
Most-Cited Works
- → Bacillaene, a Novel Inhibitor of Procaryotic Protein Synthesis Produced by Bacillus subtilis: Production, Taxonomy, Isolation, Physico-chemical Characterization and Biological Activity.(1995)204 cited
- → Eupenifeldin, a novel cytotoxic bistropolone from Eupenicillium brefeldianum.(1993)64 cited
- → Fusaricide, a New Cytotoxic N-Hydroxypyridone from Fusarium sp.(1996)56 cited
- → BMS-182123, a Fungal Metabolite that Inhibits the Production of TNF-.ALPHA. by Macrophages and Monocytes.(1996)51 cited
- → Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880(1997)49 cited
- → Harziphilone and Fleephilone, Two New HIV REV/RRE Binding Inhibitors Produced by Trichoderma harzianum.(1996)46 cited
- → 10'-Desmethoxystreptonigrin, a novel analog of streptonigrin.(1992)37 cited
- → Glucolipsin A and B, Two New Glucokinase Activators Produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii.(1999)33 cited
- → Ascosteroside, a New Antifungal Agent from Ascotricha amphitricha. I. Taxonomy, Fermentation and Biological Activities.(1996)23 cited
- → BMS-192548, a Tetracyclic Binding Inhibitor of Neuropeptide Y Receptors, from Aspergillus niger WB2346. I. Taxonomy, Fermentation, Isolation and Biological Activity.(1995)23 cited